Neurogenic Differentiation of Dental Pulp Stem Cells to Neuron-like Cells in Dopaminergic and Motor Neuronal Inductive Media
Overview
Affiliations
Background/purpose: Dental pulp stem cells (DPSCs) have been proposed as a promising source of stem cells in nerve regeneration due to their close embryonic origin and ease of harvest. The aim of this study was to evaluate the efficacy of dopaminergic and motor neuronal inductive media on transdifferentiation of human DPSCs (hDPSCs) into neuron-like cells.
Methods: Isolation, cultivation, and identification of hDPSCs were performed with morphological analyses and flow cytometry. The proliferation potential of DPSCs was evaluated with an XTT [(2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide)] assay. Media for the induction of dopaminergic and spinal motor neuronal differentiation were prepared. The efficacy of neural induction was evaluated by detecting the expression of neuron cell-specific cell markers in DPSCs by immunocytochemistry and quantitative real-time reverse transcription polymerase chain reaction (RT-PCR).
Results: In the XTT assay, there was a 2.6- or 2-fold decrease in DPSCs cultured in dopaminergic or motor neuronal inductive media, respectively. The proportions of βIII-tubulin (βIII-tub), glial fibrillary acidic protein (GFAP), and oligodendrocyte (O1)-positive cells were significantly higher in DPSCs cultured in both neuronal inductive media compared with those cultured in control media. Furthermore, hDPSC-derived dopaminergic and spinal motor neuron cells after induction expressed a higher density of neuron cell markers than those before induction.
Conclusion: These findings suggest that in response to the neuronal inductive stimuli, a greater proportion of DPSCs stop proliferation and acquire a phenotype resembling mature neurons. Such neural crest-derived adult DPSCs may provide an alternative stem cell source for therapy-based treatments of neuronal disorders and injury.
Wu Y, Sun J, Wang W, Wang Y, Friedrich R Front Bioeng Biotechnol. 2024; 12:1324049.
PMID: 38562666 PMC: 10982513. DOI: 10.3389/fbioe.2024.1324049.
Mechanobiology of Dental Pulp Cells.
Bryniarska-Kubiak N, Basta-Kaim A, Kubiak A Cells. 2024; 13(5.
PMID: 38474339 PMC: 10931140. DOI: 10.3390/cells13050375.
Disease Modifying Strategies in Multiple Sclerosis: New Rays of Hope to Combat Disability?.
Bellanca C, Augello E, Mariottini A, Bonaventura G, La Cognata V, Di Benedetto G Curr Neuropharmacol. 2024; 22(8):1286-1326.
PMID: 38275058 PMC: 11092922. DOI: 10.2174/1570159X22666240124114126.
Wang W, Sun J, Aarabi G, Peters U, Fischer F, Klatt J Front Pharmacol. 2023; 14:1277075.
PMID: 37841936 PMC: 10568071. DOI: 10.3389/fphar.2023.1277075.
Prateeksha P, Naidu P, Das M, Barthels D, Das H Stem Cell Rev Rep. 2023; 19(8):2886-2900.
PMID: 37642902 DOI: 10.1007/s12015-023-10607-0.